CIK 0001504776
- Large accelerated filer
Warby Parker Inc.
Sign in to watch- Ticker
- WRBY
- Exchange
- NYSE
- Industry
- Ophthalmic Goods
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 800423634
- Phone
- +1 646-847-7215
- Business address
- 233 SPRING STREET, 6TH FLOOR EAST, NEW YORK, NY, 10013
- Former names
- JAND, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,861,485
- in 5 filings, $7.9M under 10b5-1 plans
Net −$7,861,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-05 | Miller Steven Clive Chief Financial Officer | Sale | −8,963 | $12.12 | $109K | 178,653 |
| 2024-03-05 | Gilboa David Abraham Co-Chief Executive Officer | Sale | −16,731 | $12.12 | $203K | 12,306 |
| 2024-03-05 | Blumenthal Neil Harris Co-Chief Executive Officer | Sale | −16,731 | $12.12 | $203K | 12,177 |
| 2024-03-04 | Miller Steven Clive Chief Financial Officer | Grant or award | +20,737 | 187,616 | ||
| 2024-03-04 | Gilboa David Abraham Co-Chief Executive Officer | Grant or award | +28,802 | 29,037 | ||
| 2024-03-04 | Blumenthal Neil Harris Co-Chief Executive Officer | Grant or award | +28,802 | 28,908 | ||
| 2024-02-09 | Miller Steven Clive Chief Financial Officer | Grant or award · Restricted Stock Units | +168,870 | 168,870 | ||
| 2023-12-14 | Miller Steven Clive Chief Financial Officer | Sale 10b5-1 | −10,875 | $12.22 | $133K | 166,879 |
| 2023-12-11 | Miller Steven Clive Chief Financial Officer | Sale 10b5-1 | −21,550 | $11.42 | $246K | 177,754 |
| 2023-12-08 | Blumenthal Neil Harris Co-Chief Executive Officer | Conversion | +56,038 | 56,144 | ||
| 2023-12-08 | Blumenthal Neil Harris Co-Chief Executive Officer | Sale | −56,038 | $10.56 | $592K | 106 |
| 2023-12-08 | Blumenthal Neil Harris Co-Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −4,545 | 3,172 | ||
| 2023-12-08 | Blumenthal Neil Harris Co-Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −4,331 | 20,072 | ||
| 2023-12-08 | Blumenthal Neil Harris Co-Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −84,295 | 843,987 | ||
| 2023-12-08 | Blumenthal Neil Harris Co-Chief Executive Officer | Exercise or conversion · Class B Common Stock | +93,171 | 4,308,925 | ||
| 2023-12-08 | Blumenthal Neil Harris Co-Chief Executive Officer | Conversion · Class B Common Stock | −56,038 | 4,252,887 | ||
| 2023-12-08 | Gilboa David Abraham Co-Chief Executive Office | Conversion | +56,038 | 56,273 | ||
| 2023-12-08 | Gilboa David Abraham Co-Chief Executive Office | Sale | −56,038 | $10.56 | $592K | 235 |
| 2023-12-08 | Gilboa David Abraham Co-Chief Executive Office | Exercise or conversion · Restricted Stock Units | −4,545 | 3,172 | ||
| 2023-12-08 | Gilboa David Abraham Co-Chief Executive Office | Exercise or conversion · Restricted Stock Units | −4,331 | 20,072 |
Page 24 of 59 · 1,167 trades